GlassScriptPhysician profile
Sylmara E Chatman
NPI 1508951633
$594.67
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $154 · 2021: $191 · 2022: $20.40 · 2023: $55.89 · 2024: $51.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $104.31 | 2020-2023 | Hetlioz |
| Novartis Pharmaceuticals Corporation | $64.17 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $56.86 | 2019-2020 | |
| Phadia US INC. | $48.05 | 2021 | |
| Pfizer INC. | $32.88 | 2021 | |
| Corium, LLC | $29.77 | 2023 | Adlarity |
| Bayer Healthcare Pharmaceuticals INC. | $27.17 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.64 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.92 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.40 | 2022 | |
| Avanir Pharmaceuticals, INC. | $20.12 | 2019 | |
| Alkermes, INC. | $19.33 | 2020 | |
| Exact Sciences Corporation | $18.80 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $16.74 | 2024 | Gemtesa |
| Astellas Pharma US INC | $16.49 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.34 | 2024 | |
| Xeris Pharmaceuticals, INC. | $16.08 | 2021 | |
| Novo Nordisk INC | $13.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.27 | 2021 | |
| Strongbridge US INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylmara Chatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.